Search For "clinical"
Bharat Biotech to undertake clinical trials in US
Updated : 4 years, 9 months ago IST
New Delhi [India], June 12 (ANI): India's first indigenous COVID-19 vaccine manufacturer Bharat Biotech on Saturday said that it will be carrying out clinical trials in the US to support the marketing application for Covaxin in the country.
Read More
Yaksha- tech assessment engine to onboard, deploy and skill tech talent wi
Updated : 4 years, 9 months ago IST
Bengaluru (Karnataka) [India], June 8 (ANI/BusinessWire India): Yaksha has emerged as the preferred partner for assessments to L&D, recruiters and delivery alike in technology companies.
Read More
Five new homeopathic drugs developed by Indian doctors at Nair Hospital sh
Updated : 4 years, 9 months ago IST
New Delhi/Mumbai [India], June 7 (ANI/PR Newswire): In breakthrough research by Indian homeopath Dr Rajesh Shah in collaboration with clinical pharmacologists at Mumbai's BYL Nair Hospital, five new homeopathic drugs have shown anti-fungal and anti-bacterial effects in a laboratory model. Th
Read More
AIIMS Delhi to start screening children for Covaxin trials from Monday
Updated : 4 years, 9 months ago IST
New Delhi [India], June 6 (ANI): The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown COVID-19 vaccine, Bharat Biotech's Covaxin, from Monday, sources said.
Read More
CSIR begins clinical trials for Niclosamide drug as Covid-19 treatment
Updated : 4 years, 9 months ago IST
New Delhi [India], June 6 (ANI): Council of Scientific and Industrial Research (CSIR) along and Laxai Life Sciences Pvt. Ltd. on Sunday initiated Phase-II clinical trial for anti-helminitic drug Niclosamide for treatment of Covid-19.
Read More
Children can't be vaccinated currently, trials on below 18 underway: Centr
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): Centre through an affidavit on Friday informed the Delhi High Court that on May 12, 2021, the Drug Controller General of India (DCGI) has permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 years to 18 years of age for its vacc
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 4 years, 9 months ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
AIIMS Delhi to start Covaxin trials on children in few days, say sources
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
'Good' bacteria show promise for clinical treatment of Crohn's disease, ul
Updated : 4 years, 10 months ago IST
Washington [US], May 30 (ANI): A new study published in Nature Communications demonstrates that a consortium of bacteria designed to complement missing or underrepresented functions in the imbalanced microbiome of inflammatory bowel disease (IBD) patients, prevented and treated chronic immun
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 4 years, 10 months ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
Plant-based dinner could reduce risk of heart disease: Study
Updated : 4 years, 10 months ago IST
Washington [US], May 27 (ANI): People who eat too many refined carbs and fatty meats for dinner have a higher risk of heart disease than those who eat a similar diet for breakfast, according to a nationwide study published in the Endocrine Society's Journal of Clinical Endocrinology and Meta
Read More